Last reviewed · How we verify
Nosocomial Pneumonia due to Escherichia Coli
Approved treatments
- Noroxin
- Floxin
- Levaquin · Generic (originally Daiichi Sankyo/J&J)
Levofloxacin is a fluoroquinolone antibacterial agent. - Ofloxacine · Assistance Publique - Hôpitaux de Paris
Competitive intelligence
For the full treatment-landscape CI brief — marketed leaders side-by-side, pipeline by phase, recent regulatory actions, sponsor landscape:
- Nosocomial Pneumonia due to Escherichia Coli patent landscape — cliff calendar, originator estates, attackable patents
- Nosocomial Pneumonia due to Escherichia Coli treatment landscape brief
- Nosocomial Pneumonia due to Escherichia Coli treatment updates RSS
Frequently asked questions about Nosocomial Pneumonia due to Escherichia Coli
What drugs treat Nosocomial Pneumonia due to Escherichia Coli?
Tracked treatments include Noroxin, Floxin, Levaquin, Ofloxacine.
What is the treatment for Nosocomial Pneumonia due to Escherichia Coli?
Standard treatment for Nosocomial Pneumonia due to Escherichia Coli includes Noroxin, Floxin, Levaquin, Ofloxacine. See the treatment landscape page for first-line, second-line and salvage options.
Related
- Treatment landscape: Nosocomial Pneumonia due to Escherichia Coli patent cliff · Nosocomial Pneumonia due to Escherichia Coli CI report
- Treatment: Noroxin
- Treatment: Floxin
- Treatment: Levaquin · Generic (originally Daiichi Sankyo/J&J)
- Treatment: Ofloxacine · Assistance Publique - Hôpitaux de Paris
- All diseases: Browse the disease index · Disease landscape hub
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing